Increased risk of cardiovascular events with coxibs and NSAIDs.
Thomas
L G
LG
D002318:Cardiovascular Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic / Q000941:ethics*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D030881:Disclosure; D028741:Ethics Committees, Clinical; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008297:Male; D011471:Prostatic Neoplasms / Q000517:prevention & control; D013450:Sulfones / Q000009:adverse effects*
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib